• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Applied Therapeutics Inc (NQ: APLT )

    5.090 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 5.090
    Bid (Size) 3.140 (15)
    Ask (Size) 6.570 (1)
    Prev. Close 5.090
    Today's Range 5.090 - 5.090
    52wk Range 1.180 - 9.390
    Shares Outstanding 114,267,382
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    CrossFirst Bankshares Posts Q2 Earnings, Joins Owens & Minor, Reddit And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
    Via Benzinga
    Applied Therapeutics Added to Russell 3000® Index
    From Applied Therapeutics
    Via GlobeNewswire

    Performance

    YTD
    +39.84%
    +39.84%
    1 Month
    +9.94%
    +9.94%
    3 Month
    +15.42%
    +15.42%
    6 Month
    +85.09%
    +85.09%
    1 Year
    +260.99%
    +260.99%

    More News

    Read More
    Top 4 Health Care Stocks That May Keep You Up At Night This Month
    Via Benzinga
    APLT Stock Earnings: Applied Therapeutics Meets EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    Applied Therapeutics Reports First Quarter 2024 Financial Results
    From Applied Therapeutics
    Via GlobeNewswire
    Applied Therapeutics: Q4 Earnings Insights
    Via Benzinga
    Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference
    From Applied Therapeutics
    Via GlobeNewswire
    Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer
    From Applied Therapeutics
    Via GlobeNewswire
    Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024
    From Applied Therapeutics
    Via GlobeNewswire
    FDA Presses Delay Button For Applied Therapeutics' First Potential Marketed Drug For Rare Disease
    Via Benzinga
    Exposures Product Safety
    Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Oxford Industries Posts Weak Results, Joins Applied Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia
    From Applied Therapeutics
    Via GlobeNewswire
    EQT, Genie Energy And Other Big Stocks Moving Lower On Monday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results
    From Applied Therapeutics
    Via GlobeNewswire
    Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Advance Auto Parts Reports Q4 Results, Joins B&G Foods, Vipshop, ADT And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    FDA Grants Review Date For Applied Therapeutics' First Commercial Product For Rare Metabolic Disorder
    Via Benzinga
    Exposures Product Safety
    Why Is Coupang (CPNG) Stock Up 4% Today?
    Via InvestorPlace
    Applied Therapeutics Inc. (NASDAQ: APLT) Records 52-Week High Wednesday Morning
    Via Investor Brand Network
    Why Is Applied Therapeutics (APLT) Stock Up 59% Today?
    Via InvestorPlace
    Applied Therapeutics Announces $100 Million Private Placement
    From Applied Therapeutics
    Via GlobeNewswire
    Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia
    From Applied Therapeutics
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.